Upperton has submitted an application to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for approval of a 7,000 sq. ft sterile manufacturing facility in Nottingham, UK. The submission follows the completion of aseptic process simulation validation batches carried
Matrix Pharma Corp has inaugurated a new oncology manufacturing facility, Unit-8, in Vizag, India. The facility is designed to support the production of highly potent active pharmaceutical ingredients (HPAPIs) for oncology applications and strengthens the company’s manufacturing infrastructure for high-potency
Lifecore Biomedical has entered into a development services agreement with Indomo to support the development of DT-001, a corticosteroid drug candidate designed to treat inflammatory acne lesions. The collaboration expands the relationship between the two companies, with Lifecore providing contract
Frontage Laboratories has completed the acquisition of Teddy Clinical Research Laboratory (Shanghai), Ltd., a clinical research laboratory service provider based in China. The transaction is intended to expand Frontage’s laboratory service capabilities and strengthen its operational footprint in China and
Altruist Biologics has introduced Altru-CON™, a formulation technology platform designed to support the development and commercialisation of high-concentration biologics. The platform enables protein concentrations of up to 200 mg/mL while achieving more than a two-fold reduction in viscosity. The technology
Minaris has launched AgentSCREEN™, a next-generation sequencing (NGS) platform designed to detect adventitious viruses in biologics and advanced therapy products. The GMP-qualified testing platform aims to support viral safety testing for pharmaceutical and biotechnology companies developing monoclonal antibodies, vaccines, and
Forma Life Sciences has launched as an independent contract development and manufacturing organization (CDMO) focused on oral solid dosage formulation development, clinical manufacturing, and commercial drug product production in the United States. The company began operations in January 2026 and
Codis has announced plans to expand its manufacturing capabilities in the United Kingdom with the purchase of a GEA Pharma-SD® type PSD-4 solvent-capable spray dryer. The equipment will be installed at the company’s 400,000-square-foot facility in Haverhill, UK, and is
CordenPharma Colorado has signed a 15-year lease for a 64,000-square-foot laboratory facility at BioMed Realty’s Flatiron Park campus in Boulder, Colorado. The new site at 5505 Central will house process development and analytical services supporting peptide active pharmaceutical ingredient (API)
FUJIFILM Biotechnologies has unveiled ShunzymeX, a new purification technology designed to simplify downstream processing for complex biologics. The technology will be presented at the Festival of Biologics conference in San Diego and is intended to support biologics development programmes by
